Analysis of factors associated with COVID-19 mortality in a triple border city
DOI:
https://doi.org/10.33448/rsd-v11i1.24149Keywords:
Coronavirus; Chronic diseases; Mortality.Abstract
This study aims to analyze the factors associated with mortality by COVID-19 in a city of the triple border. This is a cross-sectional, descriptive and exploratory research of quantitative nature, to be carried out with the compulsory notification forms of deaths by coronavirus, the epidemiological surveillance of the municipality of Foz do Iguaçu-PR. The data were grouped into several categories: sex, age, color, nationality, education, need for hospitalization, type of transmission and morbidities. Thus, through this study, we identified higher mortality in the male group, aged between 70 and 79 years, white, Brazilian nationality, low education, need for hospitalization, type of community transmission and among the comorbidities were more present: hypertension, BMI above the appropriate, diabetes, cardiovascular and pulmonary diseases. Some individuals presented one or more comorbidity, the rate of people without comorbidities or under investigation were low. Thus concluding that these factors associated with the coronavirus showed influence on the mortality of these individuals.
References
Batista, A., Antunes, B., Faveret, G., Peres, I., Marchesi, J., Cunha, P. J., Dantas, L., Bastos, L., Carrilho, L., Aguilar, S., Baião, F., Maçaira, P., Hamacher, S., & Bozza, F. (2020). Análise socioeconômica da taxa de letalidade da COVID-19 no Brasil https://www.sites.google.com/view/nois-pucrio/publica%C3%A7%C3%B5es?authuser=0
Carneiro, J; & Allis, T. (2021). Como se move o turismo durante a pandemia da COVID-19? Revista Brasileira de Pesquisa em Turismo, 15(1), 1-23.
Ejaz, H., Alsrhani, A., Zafar, A., Javed, H., Junaid, K., Abdalla, A. E., Abosalif, K. O. A., Ahmed, Z., & Younas, S. (2020). COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 13 (12): 1833–1839.
Fredrich, V. C., Asr, A. M., Champion, L., Mello, T., Silva, J. V., Ziak, M., Bellizzi, A., Lopes, M., Junior, N., & Preto, C. (2020). Perfil de óbitos por covid-19 no estado do paraná no início da pandemia: estudo transversal. Revista de saúde pública do paraná, 3(1), 62-74.
Grasselli, G., Greco, M., Zanella, A., Albano, G., Antonelli, M., Ballani, G., et al. (2020). Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med. 180(10): 1–11.
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., & Castelli A. (2020). Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 323(16):1574–1581.
Melo, R. R. (2020). Análise do perfil epidemiológico dos óbitos por COVID-19 em Santa Catarina durante a pandemia de coronavírus até a 33ª semana epidemiológica do ano de 2020 https://repositorio.ufsc.br/handle/123456789/218111.
Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G (2020). Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill, 25(10), 1-5.
Neto, O. T., Garcia, L. S. T., & Spinussi, E., (2020). Pandemia de COVID-19, as fronteiras pelo mundo e o transporte aéreo na Itália https://journals.openedition.org/confins/27577
Opas. Organização pan-americana de saúde (2021). Histórico da pandemia de covid 19. S.D. https://www.paho.org/pt/covid19
Rao, S., Lau, A., & So H. C. (2020). Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: a Mendelian randomization analysis highlights tentative relevance of diabetes-related traits. Diabetes Care.
Ryan, D.h., Ravussin, E., & Heymsfield, S. (2020). COVID 19 and the patient with obesity—the editors speak out. Obesity. 28(5):847.
Sahebnasagh, A., Avan, R., Saghafi, F., Mojtahedzadeh, M., Sadremomtaz, A., Arasteh, O., Tanzifi, A., Faramarzi, F., Negarandeh, R., Safdari, M., Khataminia, M., Ghaleno, R. H., Habtemariam, S., & Khoshi, A. (2020). Pharmacological treatments of COVID-19. O Pharmacol, 72, 1446-1478.
Singh, K. A., Gupta, R., & Misra, A. (2020). Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Sciencedirect, 14(4), 283-287.
Souza, A. T., Siqueira, S. B., & Grassiolli, S. (2020). Obesidade, Comorbidades e Covid19: Uma breve revisão de literatura. Ciências Da Saúde, 6(1), 72–82.
Streeck, H. et al. Infection fatality rare of SARS-CoV2 in a super-spreading event in Germany. Rev. Nature Communications. Nov, 2020.
Wachholz, A. P., Moreira, G. V., Oliveira, D., Watanabe, H., & Boas, V. F. J. P (2016). Ocorrência de infecção e mortalidade por covid-19 em casas de idosos no brasil https://preprints.scielo.org/index.php/scielo/preprint/view/1032/version/1096
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., & Zhang J. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 323(11):1061–1069.
Who. World Health Organization (2020). Coronavirus disease 2019 (COVID-19) Situation report — 141. Geneva, Switzerland: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200609-covid-19-sitrep-141.pdf?sfvrsn=72fa1b16_2.
Who. World Health Organization (2021). Infection prevention and control during health care when COVID-19 is suspected https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC-2021.1
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., & Guo Q. (2020). Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 94:91–95.
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases, 94, 91–95.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 William da Costa Moreira; Wesley Martins
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
